Restoring leukemia cell function from the inside out
- PMID: 28620100
- DOI: 10.1182/blood-2017-04-776344
Restoring leukemia cell function from the inside out
Conflict of interest statement
Conflict-of-interest disclosure: J.G.G. has received honoraria from Janssen, Pharmacyclics, Abbvie, Roche, Celgene, Acerta, Gilead, and TG Therapeutics.
Comment on
-
A phase 1 clinical trial of single-agent selinexor in acute myeloid leukemia.Blood. 2017 Jun 15;129(24):3165-3174. doi: 10.1182/blood-2016-11-750158. Epub 2017 Mar 23. Blood. 2017. PMID: 28336527 Free PMC article. Clinical Trial.
-
Selective inhibition of nuclear export with selinexor in patients with non-Hodgkin lymphoma.Blood. 2017 Jun 15;129(24):3175-3183. doi: 10.1182/blood-2016-11-750174. Epub 2017 May 3. Blood. 2017. PMID: 28468797 Clinical Trial.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical